Effect of Atogepant on Migraine-Specific Quality of Life Questionnaire and Headache Impact Test-6 in a 12-Week, Double-blind, Randomized, Phase 3 (PROGRESS) Trial for Preventive Treatment of Chronic Migraine

Authors
Category Primary study
ConferenceCephalalgia
Year 2022
This article has no abstract
Epistemonikos ID: 95c7f64e553f57bf198f2cbb1518f44dd4620292
First added on: Apr 30, 2026